Medical care for chronic-phase stroke in Japan

Neurologia Medico-Chirurgica

Volumn 52, Issue 4, 2012, Pages 175-180

  Hattori, Naoyuki ^a   Hirayama, Teruyasu ^a   Katayama, Yoichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic phase stroke; Medical cost; Quality of life; Utility

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC PHASE STROKE; COST UTILITY ANALYSIS; DAILY LIFE ACTIVITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; QUALITY OF LIFE; RANKIN SCALE; STROKE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HUMANS; JAPAN; LONG-TERM CARE; MALE; MIDDLE AGED; NURSING HOMES; PROSPECTIVE STUDIES; STROKE;

EID: 84860010168     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.52.175     Document Type: Article

References (17)

1. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16: 199-208, 1990.
2. Goldman L, Gordon DJ, Rifkind BM, Hulley SB, Detsky AS, Goodman DW, Kinosian B, Weinstein MC: Cost and health implications of cholesterol lowering. Circulation 85: 1960-1968, 1992.
3. Ikegami N, Hukuhara S, Shimozuma K, Ikeda S (eds): [Handbook of Estimation for QOL]. Tokyo, Igakushoin Ltd, 2001, pp 45-49 (Japanese).
4. Japan National Council of Social Welfare, Department of Welfare for Elderly Persons: [Report of Survey Program for Service Supply Indices]. Tokyo, Japan National Council of Social Welfare Press, 1995, pp 131-193 (Japanese).
5. King JT Jr, Glick HA, Mason TJ, Flamm ES: Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. J eurosurg 83: 403-412, 1995.
6. King JT Jr, Tsevat J, Lave JR, RobertsMS:Willingness to pay for a quality-adjusted life year: Implications for societal health care resource allocation. Med Decis Making 25: 667-677, 2005.
7. Lamers LM, Stupp R, van den Bent MJ, Al MJ, Gorlia T,Wasserfallen JB,Mittmann N, Jin Seung S, Crott R, Uyl-de Groot CA; EORTC 26981/22981 NCI-C CE3 Intergroup Study: Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/ 22981 NCI-C CE3 Intergroup Study. Cancer 112: 1337-1344, 2008.
8. Lee WY, Cho DY, Lee HC, Chuang HC, Chen CC, Liu JL, Yang SN, Liang JA, Ho LH: Outcomes and costeffectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors. J Clin Neurosci 16: 630-634, 2009.
9. Maud A, Lakshminarayan K, Suri MF, Vazquez G, Lanzino G, Qureshi AI: Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg 110: 880-886, 2009.
10. Ministry of Health, Labour and Welfare, Policy Planning and Research Department, Wage Census: [Basic Survey on Wage Structure 2009]. Tokyo, Ministry of Finance Press, 2010, pp 2-101 (Japanese).
11. Nancy D, Parkin D: Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 13: 437-452, 2004.
12. Nord E: Methods for quality adjustment of life years. Soc Sci Med 34: 559-569, 1992.
13. Ohkusa Y: [Empirical research for the critical value of expenditure per QALY]. Iryo To Shakai 13: 121-130, 2003 (Japanese).
14. Ohkusa Y, Sugawara T.: [Research for willingness to pay for one QALY gain]. Iryo To Shakai 16: 157-165, 2006 (Japanese).
15. Sampson FC, Hayward A, Evans G,Morton R, Collett B: Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 96: 1052-1057, 2002.
16. Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 5: 1-30, 1986.
17. William A: Economics of coronary artery bypass grafting. BMJ 291: 326-329, 1985.